DK1608655T3 - Pyrroloimidazolderivater, fremstillingen deraf, farmaceutiske præparater indeholdende disse og anvendelse deraf som nootrope midler - Google Patents

Pyrroloimidazolderivater, fremstillingen deraf, farmaceutiske præparater indeholdende disse og anvendelse deraf som nootrope midler

Info

Publication number
DK1608655T3
DK1608655T3 DK04741432T DK04741432T DK1608655T3 DK 1608655 T3 DK1608655 T3 DK 1608655T3 DK 04741432 T DK04741432 T DK 04741432T DK 04741432 T DK04741432 T DK 04741432T DK 1608655 T3 DK1608655 T3 DK 1608655T3
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
nootropic agents
action
Prior art date
Application number
DK04741432T
Other languages
Danish (da)
English (en)
Inventor
Carlo Farina
Stefania Gagliardi
Carlo Parini
Marisa Martinelli
Carla Ghelardini
Dipartimento Di O
Original Assignee
Brane Discovery S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brane Discovery S R L filed Critical Brane Discovery S R L
Application granted granted Critical
Publication of DK1608655T3 publication Critical patent/DK1608655T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04741432T 2003-03-24 2004-03-22 Pyrroloimidazolderivater, fremstillingen deraf, farmaceutiske præparater indeholdende disse og anvendelse deraf som nootrope midler DK1608655T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000573A ITMI20030573A1 (it) 2003-03-24 2003-03-24 Composti ad azione nootropica, loro preparazione,
PCT/EP2004/050339 WO2004085438A2 (fr) 2003-03-24 2004-03-22 Composes presentant une action nootropique, leur preparation, compositions pharmaceutiques les contenant, et leur utilisation

Publications (1)

Publication Number Publication Date
DK1608655T3 true DK1608655T3 (da) 2008-11-03

Family

ID=33042696

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04741432T DK1608655T3 (da) 2003-03-24 2004-03-22 Pyrroloimidazolderivater, fremstillingen deraf, farmaceutiske præparater indeholdende disse og anvendelse deraf som nootrope midler

Country Status (23)

Country Link
US (3) US7544705B2 (fr)
EP (1) EP1608655B8 (fr)
JP (1) JP4920408B2 (fr)
CN (1) CN100522963C (fr)
AT (1) ATE401327T1 (fr)
AU (1) AU2004224087B2 (fr)
BR (1) BRPI0408601A (fr)
CA (1) CA2520008C (fr)
CY (1) CY1108401T1 (fr)
DE (1) DE602004015089D1 (fr)
DK (1) DK1608655T3 (fr)
EA (1) EA009558B1 (fr)
ES (1) ES2309534T3 (fr)
HR (1) HRP20050833A2 (fr)
IT (1) ITMI20030573A1 (fr)
NO (1) NO20054898L (fr)
NZ (1) NZ543154A (fr)
PL (2) PL378939A1 (fr)
PT (1) PT1608655E (fr)
RS (1) RS20050725A (fr)
SI (1) SI1608655T1 (fr)
WO (1) WO2004085438A2 (fr)
ZA (1) ZA200508578B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
EP1925304A1 (fr) * 2006-11-15 2008-05-28 Nikem Research S.R.L. Pyrrolo[1,2-a]imidazoledione pour traitement d'une neuropathie périphérique induite par une chimiothérapie
AU2012201853B2 (en) * 2007-04-16 2013-06-27 Neurotune Ag Use of dimiracetam in the treatment of chronic pain
ITMI20070770A1 (it) * 2007-04-16 2008-10-17 Brane Discovery S R L Impiego di dimiracetam nel trattamento del dolore cronico
ES2865504T3 (es) 2008-10-16 2021-10-15 Univ Johns Hopkins Procedimientos y composiciones para la mejora de la función cognitiva
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
AU2011215870B2 (en) * 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
PT2598504E (pt) * 2010-07-26 2014-07-14 Neurotune Ag Novo processo de fabrico de dimiracetam
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ, インコーポレイテッド 認知機能を改善するための方法および組成物
WO2014144663A1 (fr) 2013-03-15 2014-09-18 The Johns Hopkins University Procédés et compositions pour améliorer la fonction cognitive
WO2016191288A1 (fr) 2015-05-22 2016-12-01 Agenebio, Inc. Compositions pharmaceutiques de lévétiracétam à libération prolongée
JOP20190251A1 (ar) 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
CN113195494B (zh) 2018-12-04 2024-06-28 美蒂斯制药公司 包含非外消旋比例的R-2-(取代的磺酰基)-六氢-吡咯并[1,2-a]吡嗪-6(2H)-酮和S-2-(取代的磺酰基)-六氢-吡咯并[1,2- a]吡嗪-6(2H)-酮的协同组合物
BR112021010739A2 (pt) 2018-12-04 2021-08-24 Metys Pharmaceuticals AG Composições sinérgicas compreendendo (r)-(2-(2-oxopirrolidina-1-il)butanamida e (s)-2-(2-oxopirrolidina-1-il)butanamida) em uma proporção não racêmica

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582838A (en) * 1984-08-24 1986-04-15 Warner-Lambert Company Derivatives of dihydro-1H-pyrrolo[1,2-c]imidazol-3,5-dione as cognition activators
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
US5200406A (en) * 1988-02-08 1993-04-06 I.S.F. Societa Per Azioni Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines
JP3400466B2 (ja) * 1991-10-28 2003-04-28 日本水産株式会社 高純度エイコサペンタエン酸またはそのエステルの製造方法
GB9123641D0 (en) * 1991-11-07 1992-01-02 Isf Spa Process
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
EP1925304A1 (fr) * 2006-11-15 2008-05-28 Nikem Research S.R.L. Pyrrolo[1,2-a]imidazoledione pour traitement d'une neuropathie périphérique induite par une chimiothérapie

Also Published As

Publication number Publication date
EP1608655B8 (fr) 2008-10-15
EP1608655B1 (fr) 2008-07-16
EA200501501A1 (ru) 2006-04-28
US7544705B2 (en) 2009-06-09
ITMI20030573A1 (it) 2004-09-25
PT1608655E (pt) 2008-10-07
ZA200508578B (en) 2007-04-25
EP1608655A2 (fr) 2005-12-28
NZ543154A (en) 2008-03-28
US20100173945A1 (en) 2010-07-08
CA2520008C (fr) 2011-08-23
CN100522963C (zh) 2009-08-05
SI1608655T1 (sl) 2008-12-31
BRPI0408601A (pt) 2006-03-07
CA2520008A1 (fr) 2004-10-07
CY1108401T1 (el) 2014-02-12
EA009558B1 (ru) 2008-02-28
AU2004224087A1 (en) 2004-10-07
WO2004085438A3 (fr) 2004-11-25
US7732473B2 (en) 2010-06-08
US20070027137A1 (en) 2007-02-01
AU2004224087B2 (en) 2010-04-01
ES2309534T3 (es) 2008-12-16
RS20050725A (sr) 2007-11-15
WO2004085438A2 (fr) 2004-10-07
CN1756757A (zh) 2006-04-05
JP4920408B2 (ja) 2012-04-18
DE602004015089D1 (de) 2008-08-28
JP2006523198A (ja) 2006-10-12
HK1083837A1 (en) 2006-07-14
HRP20050833A2 (en) 2006-02-28
NO20054898L (no) 2005-10-24
US20090163565A1 (en) 2009-06-25
PL1608655T3 (pl) 2009-03-31
ATE401327T1 (de) 2008-08-15
PL378939A1 (pl) 2006-06-12

Similar Documents

Publication Publication Date Title
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
DK1608655T3 (da) Pyrroloimidazolderivater, fremstillingen deraf, farmaceutiske præparater indeholdende disse og anvendelse deraf som nootrope midler
DK1611088T3 (da) Hydroxymater som terapeutiske midler
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
NO20076447L (no) Bicykliske derivater som modulatorer av ionekanaler
WO2006052718A8 (fr) Utilisation therapeutique d'inhibiteurs de farnesyltransferase et procedes de controle de leur efficacite
ATE397930T1 (de) Verwendung von oxazolidinon-chinolin-hybrid- antibiotika zur behandlung von anthrax und anderen infektionen
MY142329A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MXPA05007462A (es) Derivados de pirrolopiridazina.
DK1641803T3 (da) Thienopyrimidinderivater som kaliumkanalinhibitorer
MY147767A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
BRPI0410727A (pt) composto, composição farmacêutica, e, uso de um composto
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
NO20055026L (no) Indolonacetamid-derivater, fremgangsmate for fremstilling og anvendelse av disse
TNSN06403A1 (en) 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
ATE366720T1 (de) Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
GB0522908D0 (en) Therapeutic agents
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
DE602004025001D1 (de) Verbindungen zur behandlung von neuropathischen schmerzen und migräne
ATE441461T1 (de) Mittel zur behandlung von infektionen